Abera Bioscience AB (ABERA)

Currency in SEK
8.30
+0.20(+2.47%)
Closed·
ABERA Scorecard
Full Analysis
Analysts anticipate sales decline in the current year
ABERA is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
7.858.30
52 wk Range
3.519.70
Key Statistics
Bid/Ask
7.85 / 8.30
Prev. Close
8.1
Open
8
Day's Range
7.85-8.3
52 wk Range
3.51-9.7
Volume
14.19K
Average Volume (3m)
9.48K
1-Year Change
84.51%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ABERA Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Net income is expected to drop this year

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Abera Bioscience AB Company Profile

Abera Bioscience AB, a platform and vaccine development company, research, design, and develops vaccines and immunotherapies based on its proprietary vaccine delivery platform in Sweden and internationally. The company’s development platform named BERA, uses for the display of antigens at the surface of outer membrane vesicles derived from genetically optimized gram-negative bacteria. Its lead vaccine candidate is a universal pneumococcal vaccine based on the platform BERA. The company also develops projects in immuno-oncology, Chlamydia, ETEC, Covid-19, and Tuberculosis. Abera Bioscience AB was incorporated in 2012 and is based in Uppsala, Sweden.

Compare ABERA to Peers and Sector

Metrics to compare
ABERA
Peers
Sector
Relationship
P/E Ratio
−170.6x−9.6x−0.5x
PEG Ratio
−1.83−0.200.00
Price/Book
14.3x6.6x2.6x
Price / LTM Sales
7.8x42.2x3.3x
Upside (Analyst Target)
1.2%12.5%43.5%
Fair Value Upside
Unlock8.2%6.3%Unlock

Earnings

Latest Release
May 30, 2025
EPS / Forecast
-- / --
Revenue / Forecast
3.57M / --
EPS Revisions
Last 90 days

ABERA Income Statement

FAQ

What Stock Exchange Does Abera Bioscience Trade On?

Abera Bioscience is listed and trades on the Spotlight Stock Market stock exchange.

What Is the Stock Symbol for Abera Bioscience?

The stock symbol for Abera Bioscience is "ABERA."

What Is the Abera Bioscience Market Cap?

As of today, Abera Bioscience market cap is 124.35M.

What Is Abera Bioscience's Earnings Per Share (TTM)?

The Abera Bioscience EPS (TTM) is -0.05.

When Is the Next Abera Bioscience Earnings Date?

Abera Bioscience will release its next earnings report on 20 Aug 2025.

From a Technical Analysis Perspective, Is ABERA a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Abera Bioscience Stock Split?

Abera Bioscience has split 0 times.

How Many Employees Does Abera Bioscience Have?

Abera Bioscience has 5 employees.

What is the current trading status of Abera Bioscience (ABERA)?

As of 05 Aug 2025, Abera Bioscience (ABERA) is trading at a price of 8.30, with a previous close of 8.10. The stock has fluctuated within a day range of 7.85 to 8.30, while its 52-week range spans from 3.51 to 9.70.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.